New sites join BONANZA Trial

Congratulations to the BONANZA Trial (Brain Oxygen Neuromonitoring in Australia and New Zealand Assessment) team with three new sites going live in 2021

Read more

START Trial goes live

Congratulations to the START Trial team who started the pilot phase of their MRFF funded study today, enrolling the first 14 residents

Read more

PADDI Trial reaches recruitment target

Congratulations to PADDI Trial for reaching the recruitment target of 8880 patients across 56 sites worldwide today

Read more

RELIEF finalist in the 2019 ACTA Clinical Trial of the Year Award

Congratulations Prof Paul Myles & the RELIEF trial team for being a finalist in the 2019 ACTA Clinical Trial of the Year Award.

Read more

INTENT Trial recruits first patient

The Intensive Nutrition Therapy comparEd to usual care iN criTically ill adults - a randomised controlled trial. The Alfred Hospital recruited their first patient today just four months after developed started on this highly customised CTMS.

Congratulations...

Read more

FEISTY Junior Goes Live

Following the completion of recruitment for FEISTY Adult Pilot in September 2017, the team at Gold Coast University Hospital have now launch FEISTY Junior at sites across Queensland.

Read more

SPICE III Study Recruitment Completed

This afternoon, around 2.30pm Melbourne time, SPICE III Study reached its recruitment target of 4000 patients across 67 sites.

Read more

ROCKet Trial Recruits first patient at Austin Health

ROCKet Trial officially commenced today with recruitment of the first patient at Austin Health.

Read more

FEISTY Pilot finished recruitment

Yesterday the FEISTY Plot Trial reached target recruitment of 100 patients well ahead of target. The first patient was recruited on January 3rd 2017.

Read more

NIDA Cardiac in the news

Three Monash University clinicians are making news this week with the initial results from the bidirectional cannula trial: http://www.9news.com.au/health/2017/08/15/00/06/melbourne-invention-saves-lives-and-limbs.

Read more

ATACAS wins ACTA Clinical Trial of the Year Award

ATACAS (Aspirin and Tranexamic Acid for Coronary Artery Surgery) has been awarded the prestigious Clinical Trial of the Year Award at the Clinical Trials 2017 National Tribute and Awards Ceremony in Sydney this month. Federal Minister for Health, Greg...

Read more